Why timing of knee replacement matters more before 50

A knee replacement is not a permanent fix. Standard implants are designed to last roughly 15 to 20 years, which works well for a patient in their late 60s or 70s. For someone in their late 30s or 40s, the arithmetic is less reassuring: a TKA performed at 42 is very likely to need complex revision surgery — a significantly harder operation — before that patient reaches retirement age. Revision rates rise with each subsequent procedure, and the results are rarely as good as the first.

That is the core reason timing matters so much. For younger and active patients, the question is not simply 'can a surgeon replace this knee?' but 'what happens to this patient 15 years later, and then 15 years after that?'

Osteochondral allograft transplantation (OCA) takes a different approach. Rather than removing the joint and replacing it with metal and plastic, it restores the damaged surface using matched donor tissue — cartilage and the underlying bone — which integrates biologically with the patient's own knee. The native joint is preserved; nothing is removed that cannot be worked around later.

The goal is to delay arthroplasty — or, in some cases, avoid it altogether — through the patient's most active decades. This is sometimes described as a biological bridge: buying meaningful years of function while keeping future options open.

This strategy makes most sense when the damage is structural but focal — a discrete area of full-thickness injury, typically post-traumatic or related to osteochondritis dissecans, rather than widespread degenerative arthritis affecting the whole joint surface. That distinction matters, because biological restoration depends on having a stable, healthy joint environment to work within.

Which patients are suitable for OCA

Suitability for OCA hinges on two questions: what kind of damage is present, and how large is the affected area?

The procedure is designed for focal, full-thickness defects graded ICRS 3 or 4 — areas where the cartilage and underlying bone have been lost down to a discrete, well-defined zone. These are typically caused by a traumatic injury or osteochondritis dissecans (OCD), a condition in which a fragment of bone and cartilage loses its blood supply and detaches. Widespread degenerative osteoarthritis, where the joint surface has deteriorated diffusely across one or more compartments, is generally outside the scope of restoration surgery of this kind.

Defect size is the other critical variable. Cell-based techniques such as MACI or ACI are appropriate for defects broadly in the 2–10 cm² range, but they depend on an intact bony scaffold beneath the cartilage. Once a defect exceeds approximately 6 cm², that scaffold is insufficient, and OCA becomes the primary surgical restoration option.

Age and activity level shape the decision alongside lesion characteristics. OCA has historically been most commonly offered to patients under 40, but published evidence now supports its use in highly active patients up to the age of 55, provided the joint environment is suitable.

Factors that weigh against OCA include a high BMI, nicotine use, and significant joint malalignment. Malalignment is not automatically disqualifying — corrective osteotomy can be performed at the same operation — but these factors are assessed carefully as part of any candidacy discussion. A consultant assessment, including imaging, is needed to confirm whether the lesion characteristics and the broader joint environment make biological restoration viable.

What the long-term survival data shows

Survivorship data from published cohort series provide the clearest basis for understanding what OCA can realistically offer — and where its limits lie.

For isolated focal grafts, the headline figure is graft survival of 80–90% at 10 years. One series of 65 grafts found 68% still in situ and functioning at a mean follow-up of nearly 13 years. In practical terms, that means a patient in their late 30s undergoing OCA for a post-traumatic defect has a reasonable expectation of remaining arthroplasty-free well into their 50s — the window of life when activity and joint demand are often highest.

The picture shifts when the lesion involves both sides of the joint. Bipolar OCA — applied to opposing surfaces, typically in more complex salvage situations — was studied in a series of 89 knees (mean age 37.9 years) and showed survivorship of 73.8% at 5 years, 66.6% at 10 years, and 58.9% at 15 years, with an overall graft failure rate of 34.8%. These are meaningfully lower figures, and patients in this situation should expect a frank discussion about what that probability gradient means for their specific trajectory.

Secondary OCA — used after a prior cartilage procedure has failed — achieves 5-year survival in the range of 79–87.8%, falling to 61–82% at 10 years across six published studies (349 patients, mean age 34.6 years). Where defects exceed 9–10 cm², failure and reoperation rates rise sharply.

These are cohort data, not randomised trial evidence, and individual outcomes vary with age, defect characteristics, and joint loading. What the figures collectively support is an honest middle ground: OCA is not a permanent solution, but in the right patient, it can realistically defer arthroplasty by a decade or more.

Outcomes for active patients aged 45 and over

For active patients in their late 40s and early 50s, a common concern is that biological restoration surgery is simply no longer an option at their age. A study published in 2022 directly challenges that assumption.

In a cohort of patients aged 45 and older treated with OCA for focal osteochondral knee injuries, 78.6% returned to their preferred sport at a mean follow-up of 37 months. Pain scores fell markedly — from a mean VAS of 7.7 before surgery to 2.0 afterwards — and mean KOOS reached 77.5. No patient in the series required conversion to any form of knee arthroplasty during the follow-up period.

The 37-month mean follow-up is shorter than the long-term survivorship series reviewed in the previous section, and data specifically tracking this age band over a decade or more remains limited. What the study does establish is that OCA can deliver meaningful functional gains and arthroplasty avoidance in a cohort historically considered at the edge of — or outside — standard indications, provided the damage is focal rather than diffuse.

This is clinically important precisely because patients in their late 40s are often those worst served by an early knee replacement: young enough to outlive the implant, active enough to place high demands on it. For this group, the evidence supports including OCA in any joint-preservation discussion. Recovery expectations and return-to-sport milestones for this age group are covered in the following section.

Improving the odds: osteotomy, risk factors, and rehabilitation

Knee alignment has a direct bearing on how long an OCA graft survives. When the joint is malaligned — in varus or valgus — load concentrates on the repaired compartment rather than distributing evenly across the joint, accelerating graft wear. Correcting that alignment at the same operation as the OCA, rather than deferring it, makes a measurable difference: across a study of 1,113 patients, concomitant osteotomy halved the reoperation rate from 34.8% to 16.3%, with no meaningful increase in complications and cost parity achieved by two years post-operatively. For patients with relevant malalignment, alignment correction is therefore a consideration to address at the index procedure — not an optional add-on to revisit at a later stage.

Two modifiable factors influence graft outcome: elevated BMI and active nicotine use. Both affect tissue healing and graft integration, and addressing them before surgery produces better conditions for the graft than attempting to manage them afterwards. Non-modifiable factors — including older patient age, bipolar lesion configuration, and larger graft volume — inform realistic expectations rather than functioning as automatic disqualifiers. They are part of the preoperative conversation, not a reason to bypass it.

Functionally, OCA restores knee range of motion beyond 120° post-operatively and improves both strength and gait across the published studies reviewed, with outcomes broadly comparable to autologous chondrocyte implantation in head-to-head functional measures. Full rehabilitation typically takes 9 to 12 months. Return to sport is generally not cleared before six months — a timeline that reflects the biological process of graft incorporation rather than arbitrary caution. That period involves progressive load-bearing, structured strengthening, and functional movement milestones rather than extended rest, and most patients find it more active than they expect.

If OCA eventually fails: the TKA fallback and what it means

Planning for the long term means being honest about what happens if OCA eventually runs its course.

Prior OCA transplantation does not present a technical barrier to subsequent total knee replacement — the arthroplasty option remains available as a fallback, and surgeons performing conversion TKA have reported no meaningful increase in operative difficulty compared with a primary replacement. That is genuinely reassuring for patients thinking ahead about their options.

What the evidence does flag, however, is a 31.4% failure rate for TKA performed after OCA — a figure drawn from a series of 35 patients who underwent conversion surgery. Closer analysis reveals why: the patients most likely to experience TKA failure were those who had accumulated the greatest number of prior knee operations before conversion. Each additional procedure before arthroplasty was negatively associated with activities-of-daily-living scores post-TKA. The 31.4% is not an argument against OCA; it is an argument for managing the preservation pathway carefully — minimising unnecessary reoperations, correcting alignment at the index procedure rather than returning for it later, and not revisiting the knee surgically unless there is clear clinical benefit.

This shapes how the entire trajectory should be understood. OCA is a bridge — a biological one with meaningful longevity, but a bridge nonetheless. The goal is to reach eventual arthroplasty older, less active, and with the shortest possible surgical history: arriving at a knee replacement once, in the best possible condition, rather than after a sequence of escalating interventions that incrementally diminish what the final operation can achieve. That longer-term arc is exactly the kind of planning that a consultant assessment, considered early, can map out in concrete terms.

1. [1] Midterm Survivorship and Clinical Outcomes in Fresh OCA Transplantation for Large Bipolar Lesions of the Knee. (2025). https://doi.org/10.1177/03635465241313139 https://doi.org/10.1177/03635465241313139
2. [2] OCA Transplantation as a Salvage Procedure After Failed Index Cartilage Surgery of the Knee: A Systematic Review. (2025). https://doi.org/10.1177/03635465241238466 https://doi.org/10.1177/03635465241238466
3. [3] Concomitant Osteotomy Reduces Risk of Reoperation Following Cartilage Restoration Procedures of the Knee. (2021). https://doi.org/10.1177/19476035211011515 https://doi.org/10.1177/19476035211011515
4. [4] Mid-term failure rates, timing, and mechanisms for OCA transplantation in the knee. (2025). https://doi.org/10.1016/j.jor.2025.03.040 https://doi.org/10.1016/j.jor.2025.03.040
5. [5] Comprehensive Patellofemoral Cartilage Restoration: Trochlear OCA, Patellar MACI, and TTO. (2026). https://doi.org/10.1177/26350254261452268 https://doi.org/10.1177/26350254261452268